Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases
Mobile Apps for Chronic Diseases Management
Assessing the Growing Role & the...

Over the past few years, the prevalence of the chronic disease has grown significantly. The rising prevalen...

Pharma News and Update for Incyte and Aptose
AstraZeneca’s Farxiga; Incyte’s Jakav...

AstraZeneca’s Farxiga Meets Primary Endpoints in Phase 3 Heart Failure Trial Farxiga, an SGLT2 inhibitor fr...

MedTech News and Updates for LivaNova, Medtronic, Conformis, Noninvasix, Masimo
Noninvasix’s LIVOx™ Central Ve...

Noninvasix Granted the US FDA Breakthrough Device Designation for Non-Invasive Monitoring Technology for Se...

pharma-news-for-gsk-idorsia-bms-novartis-lilly-cantex-viatris-biocon
GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, an...

GSK’s Covifenz, A Plant-Based COVID Vaccine, Receives First Approval The recombinant COVID-19 vaccine developed by Medicago, now known as Covifenz, has received approval in Canada, the company'...


recent-pharma-happenings-for-amgen-teneobio-biogen-ionis-abbvie-signifier
Amgen acquires Teneobio for $2.5B; Signifier scores $35M; Biogen-Ionis’ drug meets a goal; AbbVie...

Teneobio and its next-gen cancer work acquired by Amgen  Amgen has penned a major new buyout deal to boost its oncology pipeline further. The biopharma is putting USD 900 million down upfr...


sleep-disorders-market-symptoms-risk-factors-types-and-treatment-options
Sleep Disorders: An Emerging Public Health Issue

Sleep is essential for the physical and mental health of the person. If a person didn’t get proper sleep, it might lead to many health complications. In recent time, due to various reasons such as...


Narcolepsy drug WAKIX
FDA approves Non-Controlled treatment for Excessive Daytime Sleepiness

The U.S. Food and Drug Administration has approved WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) in adult patients with narcolepsy. The Narcolepsy therapy, developed by HARMONY th...


Recent Pharma News
Notizia

Bluebird declares the price of its gene therapy- Zynteglo Bluebird Bio has set the price of its gene therapy Zynteglo at USD 1.8 million. Zynteglo, so far, has only been approved for trea...


machine learning
Machine Learning Models to Help Predicting Cancer Symptoms, Plan Treatment

In what could be regarded as a first of its kind, researchers from the Centre for Vision, Speech and Signal Processing at the University of Surrey in the United Kingdom have recently reported ...


Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Acute Myeloid Leukemia Newsletter
Acute Myeloid Leukemia...

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...